Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
about
Codelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorDefective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition.Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity.Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patientsGemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.Preparation of thermo/pH-sensitive reduced graphene oxide interpenetrating hydrogel nanocomposites for co-delivery of paclitaxel and epirubicin
P2860
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@en
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@nl
type
label
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@en
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@nl
prefLabel
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@en
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@nl
P2093
P1476
Clinical and pharmacologic stu ...... with metastatic breast cancer.
@en
P2093
A Bertuzzi
A Locatelli
C Materazzo
C Spreafico
G Grasselli
P304
P356
10.1200/JCO.2001.19.8.2222
P407
P577
2001-04-01T00:00:00Z